1-4 of 4
Doug Coyle
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Benefits, Harms, and Cost-Effectiveness of Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism: A Decision Analytic Modelling Study

Faizan Khan, Doug Coyle, Kednapa Thavorn, Sasha van Katwyk, Tobias Tritschler, Brian Hutton, Gregoire Le Gal, Marc A. Rodger, Dean Fergusson
Journal: Blood
Blood (2022) 140 (Supplement 1): 7858–7859.
https://doi.org/10.1182/blood-2022-158006
Published: 2022
Journal Articles

A Decision Model to Estimate Risk Thresholds for Guiding Duration of Anticaogulation in Unprovoked Venous Thromboembolism

Faizan Khan, BSc, Kednapa Thavorn, MPharm, PhD, Doug Coyle, MA, MSc, PhD, Marc A Rodger, MD MSc, FRCPC
Journal: Blood
Blood (2017) 130 (Supplement 1): 4641.
https://doi.org/10.1182/blood.V130.Suppl_1.4641.4641
Published: 2017
Journal Articles

Bendamustine and Rituximab Versus Conventional Chemoimmunotherapy As a Frontline Treatment for Patients with Indolent B-Cell Lymphoma: A Cost-Effectiveness Analysis

Andrew Aw, MD MEng, FRCPC, Kathryn Coyle, BScPharm, MSc, Isabelle Bence-Bruckler, MD FRCPC, Christopher N. Bredeson, MD MSc, FRCPC, Doug Coyle, MA, MSc, PhD
Journal: Blood
Blood (2016) 128 (22): 1186.
https://doi.org/10.1182/blood.V128.22.1186.1186
Published: 2016
Journal Articles

Transfusion of Red Cells in Hematopoietic Stem Cell Transplantation (TRIST Study): A Randomized Controlled Trial Evaluating 2 Red Cell Transfusion Thresholds

Jason Tay, MDFRCPC MSc, David S. Allan, MD FRCPC, Elizabeth Chatelain, Doug Coyle, Mohamed Elemary, MD MSc,PhD, William Petrcich, Timothy Ramsay, Alan Tinmouth, MD FRCPC, Irwin Walker, MBBS, Anargyros Xenocostas, MD, Dean Fergusson, MHA, PhD
Journal: Blood
Blood (2016) 128 (22): 1032.
https://doi.org/10.1182/blood.V128.22.1032.1032
Published: 2016